Teal Health is one step closer to bringing at-home cervical cancer screening to the United States after being granted Breakthrough Device status by the FDA for its at-home self-collect cervical cancer screening device, the Teal Wand.
Teal Wand replaces the traditional in-office pap smear with a speculum and brush, and it replaces an invasive exam with a more comfortable, private procedure. After collecting their own sample, users will mail their sample to a laboratory for testing on an FDA-approved diagnostic test for primary screening of high-risk HPV. Through the Teal Health portal, users get their results, plus access to women's health providers.
Since one in four women in the United States are not up to date on cervical cancer screening, this self-screening device is poised to make at-home tests more accessible.
Why This Trend Is Growing
- At-home Cervical Cancer Screening
- Expanding accessibility to cervical cancer screening through at-home self-collection devices offers a convenient and private alternative to traditional in-office procedures.
- Breakthrough Device Status
- Achieving FDA Breakthrough Device status enables innovative healthcare solutions to advance rapidly and gain credibility in the market.
- Women's Health Technology
- Integrating technology in women's health for self-screening devices enhances user empowerment and preventive healthcare management.
Industries Being Reshaped
- Healthcare Technology
- The healthcare technology sector presents opportunities for developing advanced self-screening devices to revolutionize preventive care solutions.
- Medical Device Manufacturing
- In the medical device manufacturing industry, there is a potential for creating non-invasive, user-friendly devices that cater to at-home health screening demands.
- Telemedicine Services
- Telemedicine services can capitalize on the integration of at-home self-screening technologies to expand remote healthcare offerings and improve patient outcomes.
